Data revealed that just one minute of downtime costs the average business $5,600.
Medical technology continues to progress quickly, and as new devices continue to be employed in the medical field, network connectivity will only increase in importance. Today, patients expect to be able to schedule telehealth appointments, communicate with their doctors virtually, and send information to their medical providers from various smart devices.
For providers to continue to meet the demands of their patients, they need to employ appropriate strategies to maximize their uptime and minimize their downtime. Even though perfect connectivity might be unrealistic, network disruptions can have a negative impact on patient care and disrupt revenue streams. In fact, Gartner found that just one minute of downtime costs the average business $5,600.
To maximize patient outcomes, there are a few steps that medical systems and practices must take.
Employ These Key Strategies To Maximize Network Uptime
As the medical field continues to rely more heavily on the internet, maximizing uptime and minimizing downtime will only become more important. Ensuring reliable network connectivity can not only improve patient outcomes but also drive revenue growth. Medical systems and physician practices should review their network connectivity strategies from time to time to ensure they have a comprehensive plan in place.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Leadership Team at The Cigna Group Revamps in Efforts to Drive Growth, Enhance Customer Focus
March 13th 2025David M. Cordani, chairman and CEO of The Cigna Group, expressed that these moves were made to “build upon our strengths for continued growth, enhance our customer focus, and deliver even greater value for those we serve."
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Navitus to Offer Unbranded Stelara Biosimilar, Remove Stelara from Formulary
March 13th 2025Lumicera Health Services, Navitus’ specialty pharmacy, has made a deal with Teva to offer an unbranded biosimilar that they estimate will save $112,000 and $336,000 per patient per year. Navitus will remove Stelara from formulary on July 1, 2025.
Read More